Art

J-GLOBAL ID：201702244701663982   Reference number：17A0960955

Predictive value of different prostate-specific antigen-based markers in men with baseline total prostate-specific antigen <2.0 ng/mL

ベースライン総前立腺特異抗原<2.0ng/mLの男性における異なる前立腺特異抗原に基づくマーカーの予測価値

Author (9)： Fujizuka Yuji (Department of Urology, Gunma University Graduate School of Medicine, Maebashi, Gunma, Japan) ,  Ito Kazuto (Department of Urology, Gunma University Graduate School of Medicine, Maebashi, Gunma, Japan) ,  Oki Ryo (Department of Urology, Gunma University Graduate School of Medicine, Maebashi, Gunma, Japan) ,  Suzuki Rie (Department of Urology, Gunma University Graduate School of Medicine, Maebashi, Gunma, Japan) ,  Sekine Yoshitaka (Department of Urology, Gunma University Graduate School of Medicine, Maebashi, Gunma, Japan) ,  Koike Hidekazu (Department of Urology, Gunma University Graduate School of Medicine, Maebashi, Gunma, Japan) ,  Matsui Hiroshi (Department of Urology, Gunma University Graduate School of Medicine, Maebashi, Gunma, Japan) ,  Shibata Yasuhiro (Department of Urology, Gunma University Graduate School of Medicine, Maebashi, Gunma, Japan) ,  Suzuki Kazuhiro (Department of Urology, Gunma University Graduate School of Medicine, Maebashi, Gunma, Japan)
Material： International Journal of Urology (Web)  (Int J Urol (Web))
Volume： 24  Issue： 8  Page： 602-609  Publication year： 2017 
JST Material Number： U0707A  ISSN： 1442-2042  Document type： Article
Article type： 原著論文  Country of issue： United States (USA)  Language： ENGLISH (EN)

Thesaurus term： prostate-specific antigen ,...
Semi thesaurus term： *serodiagnosis ,...

Register(free) or Log In to access     To see more with JDream III (charged).   {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=17A0960955&from=J-GLOBAL&jstjournalNo=U0707A") }}

Author keywords (5)： free prostate-specific antigen ,  proprostate-specific antigen ,  prostate cancer ,  prostate-specific antigen ,  screening

JST classification (3)： Diagnosis of tumors(=neoplasms)  (GE03020J) ,  Urogenital tumors(=neoplasms)  (GM04000S) ,  Biochemistry of antigens,antibodies,complements  (ED04020L)

Reference (23)：

• Center MM, Jemal A, Lortet-Tieulent J et al. International variation in prostate cancer incidence and mortality rates. Eur. Urol. 2012; 61: 1079-92.
• Ito K. Prostate cancer in Asian men. Nat. Rev. Urol. 2014; 11: 197-212.
• Schröder FH, Hugosson J, Roobol MJ et al. Screening and prostate cancer mortality: results of the European Randomised Study of Screening for Prostate Cancer (ERSPC) at 13 years of follow-up. Lancet 2014; 384: 2027-35.
• Hugosson J, Carlsson S, Aus G et al. Mortality results from the Göteborg randomized population - based prostate - cancer screening trial. Lancet Oncol. 2010; 11: 725-32.
• Ito K, Raaijmakers R, Roobol M, Wildhagen M, Yamanaka H, Schröder FH. Prostate carcinoma detection and increased prostate-specific antigen levels after 4 years in Dutch and Japanese males who had no evidence of disease at initial screening. Cancer 2005; 103: 242-50.

Terms in the title (7)： ベースライン ,  前立腺特異抗原 ,  ML ,  男性 ,  マーカー ,  予測 ,  価値